Maggie Yiin

Skadden - UNITED STATES


Maggie Yiin's competencies

Practice Area Jurisdiction Rank Agg. Deals Value Clients Dimension N. of Transactions Last Quarter
Corporate M&AUNITED STATES2646550251
Practice Area Jurisdiction Rank Agg. Deals Value Clients Dimension N. of Transactions Last Quarter

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

FusionCharts will load here.

Technical skills

FusionCharts will load here.

Efficiency

FusionCharts will load here.


Effectiveness

FusionCharts will load here.



Perceived Added Value

FusionCharts will load here.

Ranking 2022: Maggie Yiin - Skadden

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Corporate M&A550251
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2021: Maggie Yiin - Skadden

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Maggie Yiin - Skadden

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Maggie Yiin's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
FusionCharts XT will load here!

Team

The chart shows a balanced list of counselor working with Maggie Yiin - based on PBV Monitor's analyzed transactions during last Twelve Mounths
FusionCharts XT will load here!

Co-Counsel

The Chart shows a balanced list of Maggie Yiin's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths

Counterparts

The Chart shows a balanced list of Maggie Yiin's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


FusionCharts will load here.

Recent experiences

GSK's $225 Million Acquisition of Remaining Royalty Interest in Trelegy Ellipta6/5/2025